Percutaneous thrombectomy for intermediate-risk or high-risk pulmonary embolism (IPG778)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 29 November 2023
Venous thromboembolic diseases: diagnosis, management and thrombophilia testing (NG158)Product type:GuidanceProgramme:NICE guidelineLast updated: 2 August 2023Published: 26 March 2020
Apixaban for preventing stroke and systemic embolism in people with non-valvular atrial fibrillation (TA275)Product type:GuidanceProgramme:Technology appraisal guidanceLast updated: 2 July 2021Published: 27 February 2013
Dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation (TA249)Product type:GuidanceProgramme:Technology appraisal guidanceLast updated: 2 July 2021Published: 15 March 2012
Edoxaban for preventing stroke and systemic embolism in people with non-valvular atrial fibrillation (TA355)Product type:GuidanceProgramme:Technology appraisal guidanceLast updated: 2 July 2021Published: 23 September 2015
Rivaroxaban for the prevention of stroke and systemic embolism in people with atrial fibrillation (TA256)Product type:GuidanceProgramme:Technology appraisal guidanceLast updated: 2 July 2021Published: 23 May 2012
Venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism (NG89)Product type:GuidanceProgramme:NICE guidelineLast updated: 13 August 2019Published: 21 March 2018
Percutaneous insertion of a cerebral protection device to prevent cerebral embolism during TAVI (IPG650)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 12 June 2019
Percutaneous mechanical thrombectomy for acute deep vein thrombosis of the leg (IPG651)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 12 June 2019
Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension (IPG554)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 27 April 2016
Edoxaban for treating and for preventing deep vein thrombosis and pulmonary embolism (TA354)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 26 August 2015
Ultrasound‑enhanced, catheter‑directed thrombolysis for deep vein thrombosis (IPG523)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 26 June 2015
Ultrasound‑enhanced, catheter‑directed thrombolysis for pulmonary embolism (IPG524)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 26 June 2015
Apixaban for the treatment and secondary prevention of deep vein thrombosis and/or pulmonary embolism (TA341)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 4 June 2015
Dabigatran etexilate for the treatment and secondary prevention of deep vein thrombosis and/or pulmonary embolism (TA327)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 17 December 2014
The geko device for reducing the risk of venous thromboembolism (MTG19)Product type:GuidanceProgramme:Medical technologies guidancePublished: 25 June 2014
Rivaroxaban for treating pulmonary embolism and preventing recurrent venous thromboembolism (TA287)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 26 June 2013
Rivaroxaban for the treatment of deep vein thrombosis and prevention of recurrent deep vein thrombosis and pulmonary embolism (TA261)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 25 July 2012
Apixaban for the prevention of venous thromboembolism after total hip or knee replacement in adults (TA245)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 25 January 2012
Thoracoscopic exclusion of the left atrial appendage (with or without surgical ablation) for non-valvular atrial fibrillation for the prevention of thromboembolism (IPG400)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 22 June 2011
Percutaneous closure of patent foramen ovale for the secondary prevention of recurrent paradoxical embolism in divers (IPG371)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 15 December 2010
Percutaneous occlusion of the left atrial appendage in non-valvular atrial fibrillation for the prevention of thromboembolism (IPG349)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 23 June 2010
Rivaroxaban for the prevention of venous thromboembolism after total hip or total knee replacement in adults (TA170)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 22 April 2009
Dabigatran etexilate for the prevention of venous thromboembolism after hip or knee replacement surgery in adults (TA157)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 24 September 2008
Artificial intelligence for analysing chest CT images (MIB243)Product type:AdviceProgramme:Medtech innovation briefingPublished: 5 January 2021
Reversal of the anticoagulant effect of dabigatran: idarucizumab (ESNM73)Product type:AdviceProgramme:Evidence summaryPublished: 24 May 2016
ClearWay RX for drug delivery to coronary artery thrombotic lesions (MIB55)Product type:AdviceProgramme:Medtech innovation briefingPublished: 11 March 2016